실적분석 2026년 7월 31일

Colgate-Palmolive ($CL) Q2 2026 Earnings Analysis — Adjusted EPS Beat, Slightly Higher Full-Year Guidance, Yet After-Hours Weakness

Earnings Scorecard

Revenue: $5.361 billion (+4.9% YoY, vs. $5.358 billion estimate) ✅ Beat

EPS: $0.99 on a base-business basis (vs. $0.95 estimate) ✅ Beat

Guidance: Raised — 2026 base-business EPS growth now mid-single digits (from low- to mid-single digits), gross margin now "roughly flat" (previously "decline"); net sales growth of 2–6% and organic sales of 1–4% maintained

Stock reaction: After-hours -1.75% (~$90) — as of 07-31 20:50 Korea time

The Positives

Earnings beat: Base-business EPS of $0.99 came in about 4% above the $0.95 estimate

Margin expansion: Gross margin of 61.5%, up 140bp YoY

Guidance raise: Full-year base-business EPS and gross margin outlook lifted slightly

The household staples maker — selling toothpaste, detergent, pet food and similar essentials — generated $5.361 billion in Q2 revenue, up 4.9% from $5.110 billion a year earlier and just above the $5.358 billion consensus. GAAP EPS of $0.86 was down 5% YoY, but base-business EPS (excluding restructuring and other one-time items) rose 8% YoY to $0.99 from $0.92, beating consensus.

Profitability stood out in particular. Gross margin climbed to 61.5% from 60.1% a year ago, and base-business operating margin edged up to 21.4%. First-half operating cash flow was $1.742 billion and free cash flow before dividends was $1.476 billion, both higher YoY. The company raised its full-year gross margin outlook from "decline" to "roughly flat," and lifted base-business EPS growth from "low- to mid-single digits" to "mid-single digits."

The Negatives

North America softness: North America net sales and organic sales both fell 3.0% YoY

Growth deceleration: Organic sales growth of 2.4% fell short of market expectations

Volume stagnation: Total volume growth stayed around 1%, keeping reliance on pricing

On the headline numbers, the earnings beat and guidance raise were encouraging, but the quality of growth leaves something to be desired. Organic sales growth — excluding FX and acquisition effects — was 2.4%, of which 0.4 percentage points was a drag from the wind-down of the private-label pet food business. Emerging markets held up well, but North America saw net sales and organic sales both decline 3.0%, with volumes also down 3.9%.

By region, Latin America (+13.7% net sales, +5.3% organic) and Asia-Pacific (+5.2% organic) led growth, while Europe, Middle East & Africa and Hill's Pet Nutrition posted only modest gains. Advertising spend was increased 15% YoY to reinvest in brands, which could be read as a near-term cost burden. GAAP operating income fell 6% YoY on one-time items, so the bottom line can look quite different before adjustments.

What Management Said

Chairman and CEO Noel Wallace noted that, despite a difficult operating environment, revenue and profit grew across a broad set of geographies and categories, with growth momentum continuing. He highlighted that net sales and organic sales rose in three of four categories and four of five operating units, and that global organic volume growth improved sequentially for the third consecutive quarter. He also stressed that gross margin, operating income, net income, EPS and free cash flow all increased versus the prior year.

At the same time, he said market volatility is expected to persist in the second half, and that — aligned with the company's 2030 strategy — the company will continue advertising investment behind premium, science-led innovation and demand creation across all channels. Full-year net sales growth guidance of 2–6% and organic sales of 1–4% were kept intact, while gross margin and base-business EPS were each moved up one notch. The market seems to be weighing North America weakness and tepid organic growth more heavily than the earnings and margin upgrades.

Market Reaction and What to Watch Next

Earnings beat estimates and full-year base-business profit and margin guidance were nudged higher, yet after-hours trading tilted to the sellers. Consumer staples investors watch closely how much volume actually grew and whether volumes are expanding — and here revenue was essentially in line, with North America contracting and organic growth in the low-single digits coming in below expectations. The 15% increase in ad spend is a positive long-term brand investment, but it can also temper near-term profitability optics.

Whether North America sales and volumes rebound in Q3, or the business continues to lean on price alone

Whether emerging-market growth in Latin America and Asia continues to offset North America weakness

Whether advertising and innovation investment translate into accelerating organic sales and market share (e.g., 41.3% global share in toothpaste)